Abstract:Like other autoimmune diseases, rheumatoid arthritis (RA) develops in distinct stages, with each phase of disease linked to immune cell dysfunction. HLA class II genes confer the strongest genetic risk to develop RA. They encode for molecules essential in the activation and differentiation of T cells, placing T cells upstream in the immunopathology. In Phase 1 of the RA disease process, T cells lose a fundamental function, their ability to be self-tolerant, and provide help for autoantibody-producing B cells. Phase 2 begins many years later, when mis-differentiated T cells gain tissue-invasive effector functions, enter the joint, promote non-resolving inflammation, and give rise to clinically relevant arthritis. In Phase 3 of the RA disease process, abnormal innate immune functions are added to adaptive autoimmunity, converting synovial inflammation into a tissue-destructive process that erodes cartilage and bone. Emerging data have implicated metabolic mis-regulation as a fundamental pathogenic pathway in all phases of RA. Early in their life cycle, RA T cells fail to repair mitochondrial DNA, resulting in a malfunctioning metabolic machinery. Mitochondrial insufficiency is aggravated by the mis-trafficking of the energy sensor AMPK away from the lysosomal surface. The metabolic signature of RA T cells is characterized by the shunting of glucose toward the pentose phosphate pathway and toward biosynthetic activity. During the intermediate and terminal phase of RA-imposed tissue inflammation, tissue-residing macrophages, T cells, B cells and stromal cells are chronically activated and under high metabolic stress, creating a microenvironment poor in oxygen and glucose, but rich in metabolic intermediates, such as lactate. By sensing tissue lactate, synovial T cells lose their mobility and are trapped in the tissue niche. The linkage of defective DNA repair, misbalanced metabolic pathways, autoimmunity, and tissue inflammation in RA encourages metabolic interference as a novel treatment strategy during both the early stages of tolerance breakdown and the late stages of tissue inflammation. Defining and targeting metabolic abnormalities provides a new paradigm to treat, or even prevent, the cellular defects underlying autoimmune disease.

Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis

Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications

Metabolic changes in fibroblast-like synoviocytes in rheumatoid arthritis: state of the art review

The interplay between inflammation and metabolism in rheumatoid arthritis

Critical Role of Synovial Tissue-Resident Macrophage and Fibroblast Subsets in the Persistence of Joint Inflammation

A Review of Proposed Mechanisms in Rheumatoid Arthritis and Therapeutic Strategies for the Disease

Metabolic reprogramming as a key regulator in the pathogenesis of rheumatoid arthritis

Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis

Metabolomics in rheumatoid arthritis: Advances and review

Metabolic Signatures of T-cells and Macrophages in Rheumatoid Arthritis.

Targeting dysregulated intracellular immunometabolism within synovial microenvironment in rheumatoid arthritis with natural products

Rheumatic diseases and metabolism: where centre and periphery meet

T-cell metabolism in rheumatoid arthritis: focus on mitochondrial and lysosomal dysfunction

Inflammation dynamically regulates steroid hormone metabolism and action within macrophages in rheumatoid arthritis

Synovial Tissue Insights into Heterogeneity of Rheumatoid Arthritis

Fibroblast-Like Synoviocytes Glucose Metabolism as a Therapeutic Target in Rheumatoid Arthritis

Cellular deconstruction of inflamed synovium defines diverse inflammatory phenotypes in rheumatoid arthritis

Metabolite-sensing GPCRs in rheumatoid arthritis

[Energy metabolism of the immune system : Consequences in chronic inflammation]

Differential effect of lactate on synovial fibroblast and macrophage effector functions

Redefinition of Synovial Fibroblasts in Rheumatoid Arthritis